Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Siponimod in intracerebral hemorrhage (phase II, placebo-controlled)
2015-005738-23Phase 2Completed
- Sponsor
- Novartis
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in intracerebral hemorrhage (ICH) comparing Siponimod arm with Placebo arm (2 arms). Primary endpoint: Modified Rankin Scale (mRS) score at Day 90. Started Dec 2017; status: completed.
02
Drugs
siponimod
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on 2015-005738-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005738-23.